AI assistant
Sanara MedTech Inc. — Director's Dealing 2022
Jul 9, 2022
33339_dirs_2022-07-08_fa4f21c8-a99b-4191-97f1-c65c03457ff1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2022-07-07
Reporting Person: STUCKERT JAMES W (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-07-07 | Common Stock | A | 4799 | — | Acquired | 833976 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10000 | Indirect |
| Common Stock | 46500 | Indirect |
| Common Stock | 70254 | Indirect |
Footnotes
F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.
F2: The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3: The reporting person serves as the general partner of the partnership.